Nadeem Sarwar | Founder And President
Eisai

Nadeem Sarwar, Founder And President, Eisai

Nadeem Sarwar, Ph.D., specializes in strategies to integrate and apply several sciences to deliver novel, precision medicines from human genetic and related sources. He has established and serves as president of the AiM Institute, which currently has assets in early stage clinical trials, late stage pre-IND and early stage preclinical discovery.

Nadeem’s research has been published in a number of leading medical journals, including the New England Journal of Medicine (NEJM), Journal of the Americam Medical Association (JAMA), and Lancet. He has presented at a variety of international scientific meetings, including the Prix Galien Foundation, American Diabetes Association and Hitachi Innovation. He has been invited to provide expert insights on the role of human genetics in drug discovery and precision medicine for several institutes globally. He obtained his doctorate in molecular & genetic epidemiology at the University of Cambridge (UK), where he studied with Professor John Danesh.

Appearances:



BioData World Congress Day 1 @ 15:05

Panel: Realising transformative innovations in health data sciences: The need for novel collaborative business models

last published: 05/Nov/20 11:55 GMT

back to speakers

Contact us

To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174

alistair.wilmot@terrapinn.com


To speak:
Edward Glanville
+44 (0)207 092 1042

edward.glanville@terrapinn.com